메뉴 열기
메뉴 닫기
메뉴 닫기

Recent Developments

|
|
[Aju News] [Legal Update] “Stop Technology Theft”… Quintuple Punitive Damages Allowed for Trade Secret Misappropriation
On February 13, 2024, Aju News shared in its news article Lee & Ko’s attorney Mr. Un Ho Kim’s remark on a recent update regarding the Act on the Prevention of Unfair Competition and Protection of Trade Secrets.  Mr. Kim explained that, with proposed amendments to the Act now passed at the Cabinet meeting, “businesses should be mindful that damages awarded in intellectual property cases could increase significantly and so is the possibility of criminal punishment, and should establish meticulous measures to prevent infringement of intellectual property rights.”  He further commented, “in the event of an intellectual property dispute, the right holder needs to actively utilize the relevant provisions in the Act.”
2024.02.13
[The Fact] Large Law Firms Work Hard as Election Law TF Competition Grows in the Pending Election
On February 11, 2024, The Fact introduced Lee & Ko’s “Election Response TF Team”. It reported that “Lee & Ko’s Election Response TF Team is featured by providing quick advice from the preparation and campaign stage of the election in case of a problem caused by the candidate’s violation of the election law prior to the election”. Attorney Jung Hwa Han, who is in charge of Lee & Ko’s Election Response TF Team, stated that the team “consists of experts who have practical experience in elections while serving in the prosecution service and court” and that “the team is capable of providing a multi-dimensional and comprehensive response at all stages from the election preparation stage to the National Election Commission inspection stage, investigation stage and trial stage”. 
2024.02.11
[Legal Times] [Employment/Labor] Hyundai Motor's 'Poor Job Performance' Justified Termination
On January 28, 2024, the Legal Times reported the latest litigation win by Lee&Ko. The 3rd Division of the Supreme Court (Chief Justice Seok-jun Oh) held that Hyundai Motor Company’s termination of Employee A for poor job performance was justified, thereby ordering the cancellation of the Central Labor Relations Commission’s decision. As a result, the Supreme Court’s decision reversed the district court’s affirmation and remanded the case to the Seoul High Court in favor of Hyundai Motor Company. Lee&Ko served as counsel to Hyundai Motor Company in the Supreme Court.
2024.01.28
[Money Today] Lee & Ko Reports Sales of KRW 3,723 Billion, Defending its 2nd Place
On January 28, 2024, Money Today reported that Lee & Ko has recorded sales of KRW 3,723 last year based on National Tax Service’s filing of VAT return. Money Today introduced that “Although the sales decreased by 1.1% year-on-year, Lee &Ko defended its second place”. 
2024.01.28
[Forbes] [ANNUAL BRIEF 2004] Interview | Jaewoo Kwak, Partner, Lee & Ko
Forbes reported an interview with Jaewoo Kwak, a partner of Lee & Ko on January 23, 2024. In the interview, Mr. Kwak, a lawyer specializing in intellectual property rights, stated that although there are currently few cases related to AI worldwide, there will be more in the future. He discussed the intellectual property market for various industries including electronics, materials, chemicals, machinery, automobiles, telecommunications, pharmaceuticals, biotechnology. He also addressed copyright issues related to AI and predicted the trends in laws and regulations governing AI use.
2024.01.23
[Etoday] [Law Firm Insight] Elite Group of Judges Joins Lee & Ko’s Litigation Group and Form the “Legal Avengers”
On January 19, 2024, Etoday introduced Lee & Ko’s litigation group. With respect to Lee & Ko’s litigation group, Etoday reported that “The group is currently operated by more than 30 professional teams with 150 lawyers and experts with extensive work experience are organically cooperating to create synergy as one team”, and that “The group is evaluated to have a powerful lineup by actively scouting elite judges from the court recently”. 
2024.01.19
[Etoday] [Law Firm Insight] Lee & Ko’s Managing Partner Sang Gon Kim states that “The Management Goal is the Homogenization of Expertise to Match the Name of Lee & Ko”
On January 19, 2024, Etoday published an interview with Mr. Sang Gon Kim, the managing partner of Lee & Ko. In his interview, Mr. Kim stated that “Lee & Ko’s management goal is to homogenize the entire law firm in expertise to match the name of ‘Lee & Ko’, the leader in the industry” and that “This is Lee & Ko’s direction of development that has not changed so far and will not change in the future”. 
2024.01.19
[Law Times] [Exclusive] 35 Fathers in 12 Large Law Firms Use Paternity Leave over 6 Years with Lee & Ko as Leader
On January 18, 2024, Law Times reported that after covering the current status of male lawyers who took paternity leave from 2018 to 2023 in 2 large domestic law firms, Lee & Ko had the largest number among the 12 law firms with 11 lawyers. Mr. Sang Gon Kim, the managing partner of Lee & Ko, told Law Times that “It is time for an atmosphere that values work-family coexistence to spread”, adding that “The management of Lee & Ko considers the parental leave of lawyers as positive”. 
2024.01.18
[Yonhap News] Upcoming Seminar on January 24, 2024: “Changes brought about by Chrome’s Third-Party Cookie Ban”
Yonhap News reported on January 18, 2024, about a seminar featuring Attorney Hwan Kyoung Ko, scheduled for January 24, 2024. The event, titled "Changes brought about by Chrome's Third-Party Cookie Ban: New Challenges and Data Strategies for the Online Media Industry", is hosted by the Digital Communication Research Center (DCRC) at Konkuk University and supported by the Google News Initiative. The seminar will feature a keynote speech by Mr. Ko titled "Implications of Strengthening Privacy Laws for the News Industry." This presentation will focus on explaining the changes in the legal landscape behind Chrome's third-party cookie ban and offer insights into how the online media sector, including news organizations, can adapt to an increasingly privacy-aware landscape.
2024.01.18
[Law Times] AI in Everyday Life and the Implications of the U.S. AI Executive Order – Hwan Kyoung KO, Lee & Ko
On January  18, 2024, an article by Attorney Hwan Kyoung KO was published in the Law Times. In the article, Mr. KO explains in detail the key elements of the U.S. AI Executive Order and states that “Based on this, I hope to see a display of leadership that further refines the Digital Bill of Rights and spearheads discussions on the establishment of global standards”. 
2024.01.18
[Joseilbo-Tax Daily] Lee&Ko Global Commerce Institute (GCI) Publishes an Issue Brief on “7 Major Global Economic and Trade Issues and the Response Strategy”
9 Jan 2024. The Joseilbo featured the new of Lee&Ko Global Commerce Institute (GCI)’s issue brief publication. Lee&Ko GCI anticipated in the “7 Major Global Economic and Trade Issues and the Response Strategy in 2024” issue brief (Volume 1, 2024) that the direction of global macroeconomic indicators for this year will be volatile. Additionally, it highlighted the escalating competition between the U.S. and China, the increasing geopolitical uncertainty, the expansion of factors disrupting global supply chains, and the anticipated worldwide spread of protectionist trade policies based on national priorities.
2024.01.09
[Chosun Biz][Law Firm Practice Skills] Lee & Ko Protects Boryung Pharmaceutical’s Right in Hypertension Treatment with KRW 50 Billion in Sales
On January 8, 2024, Chosun Biz reported Lee & Ko’s recent win for Boryung Pharmaceutical, noting that “as the efficacy of Dukarb®, Boryung’s hypertension drug, went viral, it became the target of other Korean pharmaceutical companies” but “Boryung has defended its Dukarb® patent all the way from the Intellectual Property Trial and Appeal Board stage to the ensuing trials, with Lee & Ko’s Healthcare Practice Group, led by Ms. Keum Nang Park, playing a key role in the defense.”  Ms. Park remarked in an interview that “this is the first time a Korean pharmaceutical company that has developed an original drug defended its patent rights in a large-scale dispute against multiple generic companies,” further noting that “we felt that this drug should be afforded patent protection especially since it was a new drug developed after many challenges in Korea, where new drug R&D is still rare.”
2024.01.08